NCT06685874View on ClinicalTrials.gov

Interstitial Lung Disease Exacerbations Study

Active, not recruitingOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

August 1, 2026

Study Completion Date

August 1, 2026

Conditions
Interstitial Lung Disease (ILD)Pulmonary Fibrosis
Trial Locations (3)

Unknown

Royal United Hospitals Bath NHS Foundation Trust, Bath

North Bristol NHS Trust, Bristol

Royal Devon University Hospitals NHS Foundation Trust, Exeter

All Listed Sponsors
collaborator

University Hospitals, Leicester

OTHER

collaborator

Nottingham University Hospitals NHS Trust

OTHER

collaborator

North Bristol NHS Trust

OTHER

collaborator

Papworth Hospital NHS Foundation Trust

OTHER_GOV

lead

Royal Devon and Exeter NHS Foundation Trust

OTHER